Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint review

Journal of Hospital Infection

Volumn 87, Issue 4, 2014, Pages 194-202

  Harbarth, S ^a   Tuan Soh, S ^b   Horner, C ^c   Wilcox, M H ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hospital Buloh   (Malaysia)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Antimicrobial resistance; Antiseptic; Disinfectant; Epidemiology; Multi drug resistant bacteria; Reduced susceptibility

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BIOCIDE; CHLORHEXIDINE; DISINFECTANT AGENT; TRICLOSAN; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; CROSS RESISTANCE; DRUG EXPOSURE; ENVIRONMENT; HEALTH CARE; HEALTH HAZARD; HUMAN; META ANALYSIS (TOPIC); NONHUMAN; PHENOTYPE; REDUCTION; REVIEW; RISK FACTOR; STANDARDIZATION; STAPHYLOCOCCUS; UNITED STATES; CROSS INFECTION; HEALTH CARE FACILITY; RISK ASSESSMENT;

ANTI-INFECTIVE AGENTS, LOCAL; CROSS INFECTION; DISINFECTANTS; DRUG RESISTANCE, BACTERIAL; HEALTH FACILITIES; HUMANS; RISK ASSESSMENT; UNITED STATES;

EID: 84905084627     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2014.04.012     Document Type: Review

References (75)

1. Cookson B. Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment. JAppl Microbiol 2013, 99:989-996.
2. Health and Safety Executive Biocides 2012, EU Biocides Regulation 528/2012 (EU BPR), Health and Safety Executive, Bootle.
3. Maillard J.Y. Mechanisms of bacterial resistance to microbicides. Russell, Hugo and Ayliffe's principles and practice of disinfection, preservation and sterilization 2013, Wiley-Blackwell, Hoboken, NJ, p. 108-120. A. Fraise, J.Y. Maillard, S. Sattar (Eds.).
4. van Klingaren B., Pullen W. Glutaraldehyde resistant mycobacteria from endoscope washers. JHosp Infect 1993, 25:147-149.
5. Russell A.D. Bacterial resistance to disinfectants: present knowledge and future problems. JHosp Infect 1999, 43(Suppl.):S57-S68.
6. Svetlikova Z., Skovierova H., Niederweis M., Gaillard J.L., McDonnell G., Jackson M. Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs. Antimicrob Agents Chemother 2009, 53:4015-4018.
7. Holdsworth S.R., Law C.J. Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli. BMC Microbiol 2013, 13:113.
8. Dubbs J.M., Mongkolsuk S. Peroxide-sensing transcriptional regulators in bacteria. JBacteriol 2012, 194:5495-5503.
9. Fraise A.P. Biocide abuse and antimicrobial resistance - a cause for concern?. JAntimicrob Chemother 2002, 49:11-12.
10. Aiello A.E., Larson E.L., Levy S.B. Consumer antibacterial soaps: effective or just risky?. Clin Infect Dis 2007, 45(Suppl. 2):S137-S147.
11. Levy S.B. Antibacterial household products: cause for concern. Emerg Infect Dis 2001, 7:512-515.
12. Maiwald M., Chan E.S. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PLoS One 2012, 7:e44277.
13. Scientific Committee on Emerging and Newly Identified Health Risks Assessment of the antibiotic resistance effects of biocides 2009, European Commission, Brussels.
14. Sheldon A.T. Antiseptic "resistance": real or perceived threat?. Clin Infect Dis 2005, 40:1650-1656.
15. Russell A.D. Do biocides select for antibiotic resistance?. JPharm Pharmacol 2000, 52:227-233.
16. Platt J.H., Bucknall R.A. MIC tests are not suitable for assessing antiseptic handwashes. JHosp Infect 1988, 11:396-397.
17. McCay P.H., Ocampo-Sosa A.A., Fleming G.T.A. Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology 2013, 156:30-38.
18. Pagedar A., Singh J., Batish V.K. Adaptation to benzalkonium chloride and ciprofloxacin affects biofilm formation potential, efflux pump and haemolysin activity of Escherichia coli of dairy origin. JDairy Res 2012, 79:383-389.
19. Mavri A., Smole Mozina S. Development of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli adapted to biocides. Int J Food Microbiol 2013, 160:304-312.
20. Rakic-Martinez M., Drevets D.A., Dutta V., Katic V., Kathariou S. Listeria monocytogenes strains selected on ciprofloxacin or the disinfectant benzalkonium chloride exhibit reduced susceptibility to ciprofloxacin, gentamicin, benzalkonium chloride, and other toxic compounds. Appl Environ Microbiol 2011, 77:8714-8721.
21. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
22. Scientific Committee on Consumer Products Opinion on triclosan 2009, European Commission, Brussels.
23. Scientific Committee on Consumer Products. Opinion on triclosan (antimicrobial resistance). Brussels: European Commission; 2010.
24. Skovgaard S., Nielsen L.N., Larsen M.H., Skov R.L., Ingmer H., Westh H. Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates. PLoS One 2013, 8:e62197.
25. Kluytmans J., Harbarth S. Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help?. Infect Control Hosp Epidemiol 2009, 30:633-635.
26. Horner C., Mawer D., Wilcox M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?. JAntimicrob Chemother 2012, 67:2547-2559.
27. Batra R., Cooper B.S., Whiteley C., Patel A.K., Wyncoll D., Edgeworth J.D. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010, 50:210-217.
28. Lee A.S., Macedo-Vinas M., Francois P., et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011, 52:1422-1430.
29. Fawley W.N., Parnell P., Hall J., Wilcox M.H. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. JHosp Infect 2006, 62:327-332.
30. Wilcox M.H., Hall J., Pike H., et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. JHosp Infect 2003, 54:196-201.
31. Otter J.A., Patel A., Cliff P.R., Halligan E.P., Tosas O., Edgeworth J.D. Selection for qacA carriage in CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates during a successful institutional infection control programme. JAntimicrob Chemother 2013, 68:992-999.
32. Ho J., Branley J. Prevalence of antiseptic resistance genes qacA/B and specific sequence types of methicillin-resistant Staphylococcus aureus in the era of hand hygiene. JAntimicrob Chemother 2012, 67:1549-1550.
33. Naparstek L., Carmeli Y., Chmelnitsky I., Banin E., Navon-Venezia S. Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae. JHosp Infect 2012, 81:15-19.
34. Maillard J.Y. Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern?. JHosp Infect 2007, 65(Suppl. 2):60-72.
35. Sakagami Y., Kajimura K. Bactericidal activities of disinfectants against vancomycin-resistant enterococci. JHosp Infect 2002, 50:140-144.
36. Weber D.J., Rutala W.A. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?. Infect Control Hosp Epidemiol 2006, 27:1107-1119.
37. Kawamura-Sato K., Wachino J., Kondo T., Ito H., Arakawa Y. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species. JAntimicrob Chemother 2010, 65:1975-1983.
38. Ledder R.G., Gilbert P., Willis C., McBain A.J. Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates. JAppl Microbiol 2006, 100:1132-1140.
39. Sasatsu M., Shimizu K., Noguchi N., Kono M. Triclosan-resistant Staphylococcus aureus. Lancet 1993, 341:756.
40. Meyer B., Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?. JHosp Infect 2010, 76:200-205.
41. Finch R.G., Metlay J.P., Davey P.G., Baker L.J. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 2004, 4:44-53.
42. Rossolini G.M., Mantengoli E., Docquier J.D., Musmanno R.A., Coratza G. Epidemiology of infections caused by multiresistant Gram-negatives: ESBLs, MBLs, panresistant strains. New Microbiol 2007, 30:332-339.
43. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe 2010 2011, Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net), European Centre for Disease Prevention and Control, Stockholm.
44. Braykov N.P., Eber M.R., Klein E.Y., Morgan D.J., Laxminarayan R. Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010. Infect Control Hosp Epidemiol 2013, 34:259-268.
45. Chung D.R., Song J.H., Kim S.H., et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011, 184:1409-1417.
46. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
47. Boyce J.M. Environmental contamination makes an important contribution to hospital infection. JHosp Infect 2007, 65(Suppl. 2):50-54.
48. Dancer S.J. The role of environmental cleaning in the control of hospital-acquired infection. JHosp Infect 2009, 73:378-385.
49. Koo V.S., O'Neill P., Elves A. Multidrug-resistant NDM-1 Klebsiella outbreak and infection control in endoscopic urology. BJU Int 2012, 110:E922-E926.
50. Milstone A.M., Elward A., Song X., et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013, 381:1099-1106.
51. Climo M.W., Sepkowitz K.A., Zuccotti G., et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37:1858-1865.
52. Climo M.W., Yokoe D.S., Warren D.K., et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. NEngl J Med 2013, 368:533-542.
53. Huang S.S., Septimus E., Kleinman K., et al. Targeted versus universal decolonization to prevent ICU infection. NEngl J Med 2013, 368:2255-2265.
54. Edmond M.B., Wenzel R.P. Screening inpatients for MRSA - case closed. NEngl J Med 2013, 368:2314-2315.
55. Patel J.B., Gorwitz R.J., Jernigan J.A. Mupirocin resistance. Clin Infect Dis 2009, 49:935-941.
56. Koburger T., Hubner N.O., Braun M., Siebert J., Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. JAntimicrob Chemother 2010, 65:1712-1719.
57. Edmiston C.E., Bruden B., Rucinski M.C., Henen C., Graham M.B., Lewis B.L. Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit?. Am J Infect Control 2013, 41:S49-S55.
58. Wang Z.X., Jiang C.P., Cao Y., Ding Y.T. Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg 2013, 100:465-473.
59. Skovgaard S., Halberg Larsen M., Norby Nielsen L., et al. Recently introduced qacA/B genes in Staphylococcus epidermidis do not increase chlorhexidine MIC/MBC. JAntimicrob Chemother 2013, 68:2226-2233.
60. Kluytmans J., Harbarth S. Control of MRSA in intensive care units. BMJ 2011, 343:d5885.
61. Bridges K., Lowbury E.J. Drug resistance in relation to use of silver sulphadiazine cream in a burns unit. JClin Pathol 1977, 30:160-164.
62. Thomas B., Sykes L., Stickler D.J. Sensitivity of urine-grown cells of Providencia stuartii to antiseptics. JClin Pathol 1978, 31:929-932.
63. Geftic S.G., Heymann H., Adair F.W. Fourteen year survival of Pseudomonas cepacia in a salts solution preserved with benzalkonium chloride. Appl Environ Microbiol 1979, 37:505-510.
64. Hendry A.T., Stewart I.O. Silver-resistant Enterobacteriaceae from hospital patients. Can J Microbiol 1979, 25:915-921.
65. Nakahara H., Kozukue H. Isolation of chlorhexidine-resistant Pseudomonas aeruginosa from clinical lesions. JClin Microbiol 1982, 15:166-168.
66. Cookson B.D., Farrelly H., Stapleton P., Garvey R.P.J., Price M.R. Transferable resistance to triclosan in MRSA. Lancet 1991, 337:1548-1549.
67. Anderson R.L. Iodophor antiseptics: intrinsic microbial contamination with resistant bacteria. Infect Control Hosp Epidemiol 1989, 10:443-446.
68. Wollmann A., Kaulfers P.M. Formaldehyde resistance in Enterobacteriaceae and Pseudomonas aeruginosa: identification of resistance genes by DNA-hybridization. Zbl Hyg 1991, 191:449-456.
69. Langsrud S., Moretro T., Sundheim G. Characterization of Serratia marcescens surviving in disinfecting footbaths. JAppl Microbiol 2003, 95:186-195.
70. Martin D.J., Denyer S.P., McDonnell G., Maillard J.Y. Resistance and cross-resistance to oxidising agents of bacterial isolates from endoscope washer disinfectors. JHosp Infect 2008, 69:377-383.
71. Rutala W.A., Stiegel M.M., Sarubbi F.A., Weber D.J. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Control Hosp Epidemiol 1997, 18:417-421.
72. Rutala W.A., White M.S., Gergen M.F., Weber D.J. Bacterial contamination of keyboards: efficacy and functional impact of disinfectants. Infect Control Hosp Epidemiol 2006, 27:372-377.
73. Wisplinghoff H., Schmitt R., Wohrmann A., Stefanik D., Seifert H. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. JHosp Infect 2007, 66:174-181.
74. Robustillo Rodela A., Diaz-Agero P.C., Sanchez S.T., Ruiz-Garbajosa P., Pita Lopez M.J., Monge V. Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures. Euro Surveill 2012, 17. pii:20086.
75. Campos G.B., Souza S.G., Lob O.T., et al. Isolation, molecular characteristics and disinfection of methicillin-resistant Staphylococcus aureus from ICU units in Brazil. New Microbiol 2012, 35:183-190.